BACKGROUND: Androgens play a role in the development of both androgenic alopecia, commonly known as male pattern baldness, and prostate cancer. We set out to study if early-onset androgenic alopecia was associated with an increased risk of prostate cancer later in life. PATIENTS AND METHODS: A total of 669 subjects (388 with a history of prostate cancer and 281 without) were enrolled in this study. All subjects were asked to score their balding pattern at ages 20, 30 and 40. Statistical comparison was subsequently done between both groups of patients. RESULTS: Our study revealed that patients with prostate cancer were twice as likely to have androgenic alopecia at age 20 [odds ratio (OR) 2.01, P = 0.0285]. The pattern of hair loss was not a predictive factor for the development of cancer. There was no association between early-onset alopecia and an earlier diagnosis of prostate cancer or with the development of more aggressive tumors. CONCLUSIONS: This study shows an association between early-onset androgenic alopecia and the development of prostate cancer. Whether this population can benefit from routine prostate cancer screening or systematic use of 5-alpha reductase inhibitors as primary prevention remains to be determined.
BACKGROUND: Androgens play a role in the development of both androgenic alopecia, commonly known as male pattern baldness, and prostate cancer. We set out to study if early-onset androgenic alopecia was associated with an increased risk of prostate cancer later in life. PATIENTS AND METHODS: A total of 669 subjects (388 with a history of prostate cancer and 281 without) were enrolled in this study. All subjects were asked to score their balding pattern at ages 20, 30 and 40. Statistical comparison was subsequently done between both groups of patients. RESULTS: Our study revealed that patients with prostate cancer were twice as likely to have androgenic alopecia at age 20 [odds ratio (OR) 2.01, P = 0.0285]. The pattern of hair loss was not a predictive factor for the development of cancer. There was no association between early-onset alopecia and an earlier diagnosis of prostate cancer or with the development of more aggressive tumors. CONCLUSIONS: This study shows an association between early-onset androgenic alopecia and the development of prostate cancer. Whether this population can benefit from routine prostate cancer screening or systematic use of 5-alpha reductase inhibitors as primary prevention remains to be determined.
Authors: Ghazi Al Edwan; Bimal Bhindi; David Margel; Karen Chadwick; Antonio Finelli; Alexandre Zlotta; John Trachtenberg; Neil Fleshner Journal: Can Urol Assoc J Date: 2016-12-12 Impact factor: 1.862
Authors: Saud Khan; Joshua Caldwell; Travis A Gerke; Sarah C Markt; Kathryn M Wilson; Amparo G Gonzalez-Feliciano; Samuel Peisch; Claire H Pernar; Rebecca E Graff; Edward L Giovannucci; Lorelei A Mucci Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-04-10 Impact factor: 4.254
Authors: Cindy Ke Zhou; Alyson J Littman; Paul H Levine; Heather J Hoffman; Sean D Cleary; Emily White; Michael B Cook Journal: Prostate Date: 2014-12-09 Impact factor: 4.104
Authors: Jean-Alfred Thomas; Jodi A Antonelli; Lionel L Banez; Catherine Hoyo; Delores Grant; Wendy Demark-Wahnefried; Elizabeth A Platz; Leah Gerber; Kathryn Shuler; Enwono Eyoh; Elizabeth Calloway; Stephen J Freedland Journal: Cancer Causes Control Date: 2013-03-26 Impact factor: 2.506
Authors: Cindy Ke Zhou; Paul H Levine; Sean D Cleary; Heather J Hoffman; Barry I Graubard; Michael B Cook Journal: Am J Epidemiol Date: 2016-01-12 Impact factor: 4.897
Authors: Cindy Ke Zhou; Ruth M Pfeiffer; Sean D Cleary; Heather J Hoffman; Paul H Levine; Lisa W Chu; Ann W Hsing; Michael B Cook Journal: J Clin Oncol Date: 2014-09-15 Impact factor: 44.544
Authors: Rui Li; Felix F Brockschmidt; Amy K Kiefer; Hreinn Stefansson; Dale R Nyholt; Kijoung Song; Sita H Vermeulen; Stavroula Kanoni; Daniel Glass; Sarah E Medland; Maria Dimitriou; Dawn Waterworth; Joyce Y Tung; Frank Geller; Stefanie Heilmann; Axel M Hillmer; Veronique Bataille; Sibylle Eigelshoven; Sandra Hanneken; Susanne Moebus; Christine Herold; Martin den Heijer; Grant W Montgomery; Panos Deloukas; Nicholas Eriksson; Andrew C Heath; Tim Becker; Patrick Sulem; Massimo Mangino; Peter Vollenweider; Tim D Spector; George Dedoussis; Nicholas G Martin; Lambertus A Kiemeney; Vincent Mooser; Kari Stefansson; David A Hinds; Markus M Nöthen; J Brent Richards Journal: PLoS Genet Date: 2012-05-31 Impact factor: 5.917